Humanoid, Inc. (HERB)

Humanoid Income Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020	FY 2015
Period Ending	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2015
Revenue	21.14	18.59	14.01	12.55	938.9
Revenue Growth (YoY)	13.71%	32.64%	11.68%	-98.66%	-7.24%
Cost of Revenue	14.1	13	10	9.31	819.74
Gross Profit	7.04	5.59	4.01	3.24	119.16
Selling, General & Admin	0.78	0.68	0.56	0.5	6.05
Operating Expenses	0.78	0.68	0.56	0.5	6.05
Operating Income	6.26	4.91	3.46	2.74	113.1
Interest Expense	-0	-0	-0	-0	-0.57
Other Non Operating Income (Expenses)	0.76	0.4	0.26	0.25	-0.65
Pretax Income	7.02	5.31	3.72	2.99	111.88
Net Income	7.02	5.31	3.72	2.99	111.88
Net Income to Common	7.02	5.31	3.72	2.99	111.88
Net Income Growth	32.21%	42.78%	24.27%	-97.33%	-18.30%
Shares Outstanding (Basic)	157	157	157	157	157
Shares Outstanding (Diluted)	157	157	157	157	157
Shares Change (YoY)	-	-	-	-	1.33%
EPS (Basic)	0.04	0.03	0.02	0.02	0.71
EPS (Diluted)	0.04	0.03	0.02	0.02	0.71
EPS Growth	32.21%	42.78%	24.26%	-97.33%	-19.38%
Free Cash Flow	2.72	0.4	1.94	-0.89	-3.31
Free Cash Flow Per Share	0.02	0.00	0.01	-0.01	-0.02
Gross Margin	33.31%	30.06%	28.64%	25.82%	12.69%
Operating Margin	29.62%	26.41%	24.67%	21.84%	12.05%
Profit Margin	33.20%	28.55%	26.52%	23.84%	11.92%
Free Cash Flow Margin	12.87%	2.15%	13.84%	-7.08%	-0.35%
EBITDA	6.66	5.21	3.76	3.02	127.47
EBITDA Margin	31.49%	28.02%	26.81%	24.05%	13.58%
D&A For EBITDA	0.4	0.3	0.3	0.28	14.37
EBIT	6.26	4.91	3.46	2.74	113.1
EBIT Margin	29.62%	26.41%	24.67%	21.84%	12.05%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.